Primary Cutaneous Cryptococcosis Caused by Cryptococcus gatti in an Elderly Patient

Imagem de Miniatura
Arquivos
art_BELDA JR._Primary_Cutaneous_Cryptococcosis_Caused_by_Cryptococcus_gatti_in_2022.PDF (2.07 MB)
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Autores
PASSERO, Luiz Felipe D.
CRIADO, Paulo R.
Citação
TROPICAL MEDICINE AND INFECTIOUS DISEASE, v.7, n.9, article ID 206, 8p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
According to the spread of Cryptococcus sp., fungal infections can be classified as primary or secondary. In primary cutaneous cryptococcosis, the fungi are restricted to the skin of the patients, without systemic involvement. The incidence of primary cutaneous cryptococcosis is high in patients with immunosuppression, and this type of infection is rarely observed in patients who are immunocompetent. In the present case report, a patient who is immunocompetent and has systemic comorbidity reported that, after skin trauma, ulcerovegetative lesions appeared in the right upper arm; the etiologic agent was identified as Cryptococcus gatti, serotype B. The cutaneous lesions healed completely after 5 months of fluconazole treatment.
Palavras-chave
cryptococcosis, cutaneous involvement, immunocompetent patient
URI
https://observatorio.fm.usp.br/handle/OPI/49188
Referências
  1. Amphornphruet A, 2018, OCUL IMMUNOL INFLAMM, V26, P518, DOI 10.1080/09273948.2017.1298820
  2. Bardhi R., 2020, DERMATOL ONLINE J, V26, P15, DOI [10.5070/D32612051361, DOI 10.5070/D32612051361]
  3. BEYT BE, 1978, NEW ENGL J MED, V298, P825, DOI 10.1056/NEJM197804132981506
  4. Campuzano A, 2018, J FUNGI, V4, DOI 10.3390/jof4010033
  5. Carvalho AK, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7068287
  6. Chang WC, 2006, CHEST, V129, P333, DOI 10.1378/chest.129.2.333
  7. Chen SCA, 2014, CLIN MICROBIOL REV, V27, P980, DOI 10.1128/CMR.00126-13
  8. Christianson JC, 2003, MED MYCOL, V41, P177, DOI 10.1080/1369378031000137224
  9. Desalermos A, 2012, EXPERT OPIN PHARMACO, V13, P783, DOI 10.1517/14656566.2012.658773
  10. do Amaral DM, 2016, AN BRAS DERMATOL, V91, P29, DOI 10.1590/abd1806-4841.20164582
  11. Firacative C, 2022, MICROORGANISMS, V10, DOI 10.3390/microorganisms10010013
  12. Firacative C, 2021, J FUNGI, V7, DOI 10.3390/jof7040282
  13. Firacative C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170554
  14. Florek M, 2022, PATHOGENS, V11, DOI 10.3390/pathogens11010008
  15. Graybill JR, 2000, CLIN INFECT DIS, V30, P47, DOI 10.1086/313603
  16. Gushiken AC, 2021, INFECT DIS CLIN N AM, V35, P493, DOI 10.1016/j.idc.2021.03.012
  17. HILL JO, 1992, J EXP MED, V175, P1685, DOI 10.1084/jem.175.6.1685
  18. Hsu E, 2022, AM J MED SCI, V363, P75, DOI 10.1016/j.amjms.2020.12.007
  19. Hurst S, 2019, MYCOSES, V62, P1029, DOI 10.1111/myc.12980
  20. Inoue N, 2021, EUR J DERMATOL, V31, P657, DOI 10.1684/ejd.2021.4143
  21. Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d
  22. Klein KR, 2009, J CLIN MICROBIOL, V47, P3669, DOI 10.1128/JCM.01072-09
  23. LACAZ Carlos da Silva, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P225
  24. Lewis ED, 2022, PROG NEURO-PSYCHOPH, V118, DOI 10.1016/j.pnpbp.2022.110576
  25. Lockhart SR, 2018, EMERG INFECT DIS, V24, P2095, DOI 10.3201/eid2411.180975
  26. Lu YY, 2013, DERMATOL SIN, V31, P90, DOI 10.1016/j.dsi.2012.07.001
  27. MacDougall L, 2011, EMERG INFECT DIS, V17, P193, DOI 10.3201/eid1702.101020
  28. Maciey Sarabeth, 2021, Clin Pract Cases Emerg Med, V5, P345, DOI 10.5811/cpcem.2021.5.52344
  29. Muselius B, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222212390
  30. Nascimento E, 2021, REV SOC BRAS MED TRO, V54, DOI 10.1590/0037-8682-0169-2021
  31. Noguchi H, 2019, MED MYCOL J, V60, P101, DOI 10.3314/mmj.19.008
  32. Nowak MA, 2020, POSTEP DERM ALERGOL, V37, P154, DOI 10.5114/ada.2020.94833
  33. Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597
  34. Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac
  35. Patel P, 2000, J AM ACAD DERMATOL, V43, P344, DOI 10.1016/S0190-9622(00)70288-X
  36. Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858
  37. Rathore SS, 2022, MICROB PATHOGENESIS, V166, DOI 10.1016/j.micpath.2022.105521
  38. Ribeiro SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166759
  39. Romiopoulos I, 2020, GERMS, V10, P388, DOI 10.18683/germs.2020.1232
  40. Setianingrum F, 2019, MED MYCOL, V57, P133, DOI 10.1093/mmy/myy086
  41. Spadari CD, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040613
  42. Tan S, 2021, CUREUS, V13, DOI 10.7759/cureus.15185
  43. Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008
  44. Vandersmissen G, 1996, ACTA CLIN BELG, V51, P111, DOI 10.1080/17843286.1996.11718496
  45. Xia XJ, 2005, MYCOSES, V48, P238, DOI 10.1111/j.1439-0507.2005.01079.x
  46. Zavala S, 2020, SEMIN RESP CRIT CARE, V41, P69, DOI 10.1055/s-0039-3400280
  47. Zhou HX, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00740

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/50